AstraZeneca says its vaccine should be effective against new coronavirus variant

"AZD1222 (AstraZeneca's vaccine candidate) contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein," an AstraZeneca spokesperson said in an email.

Reuters

December 23, 2020 / 07:38 AM IST

Source: Reuters

British drugmaker AstraZeneca Plc told Reuters on Tuesday that its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.

"AZD1222 (AstraZeneca's vaccine candidate) contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein," an AstraZeneca spokesperson said in an email.

Reuters

TAGS: #coronavirus #Covid-19 #World News

first published: Dec 23, 2020 07:31 am

Watch

• The Indian companies that made the most from Atmanirbhar Bharat Watch more
• Trade setup for Wednesday: Top 15 things to know before Opening Bell Watch more
• Ideas For Profit | Kilpest India posts robust Q2 FY21 numbers; what should investors do with stock? Watch more
• Business Insight | CII bats for bad banks in pre-budget talks: A look at the workings of a bad bank Watch more

Must Listen

Coronavirus Essential | New guidelines for passengers arriving from UK; vaccine can be adapted against the mutant COVID-19 strain in six weeks, says BioNTech

stay updated

Subscribe to our Daily Newsletter

submit

Get Daily News on your Browser Enable